{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By ROBERT CYRAN", "person": [{"rank": 1, "role": "reported", "firstname": "Robert", "organization": "", "lastname": "CYRAN"}]}, "abstract": null, "type_of_material": "News", "word_count": "388", "lead_paragraph": "The health care giant is criticized by many investors for its mediocre shareholder returns and its lack of merger-and-acquisition activity.", "pub_date": "2016-06-03T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Johnson &amp; Johnson Is Urged to Slim Down", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "snippet": "The health care giant is criticized by many investors for its mediocre shareholder returns and its lack of merger-and-acquisition activity.", "multimedia": [], "web_url": "http://www.nytimes.com/2016/06/03/business/dealbook/johnson-johnson-is-urged-to-slim-down.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Eli Lilly and Company", "name": "organizations"}, {"rank": "2", "is_major": "N", "value": "Johnson & Johnson", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Abbott Laboratories", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Medical Devices", "name": "subject"}], "blog": [], "_id": "57509af838f0d86ce33330ac", "source": "The New York Times"}